Actinic Keratosis Market Outlook Through 2030: Growth Trends and Forecast

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Actinic Keratosis Market In 2026 And 2030?

The actinic keratosis market has shown strong growth in recent years. It is projected to increase from $8.42 billion in 2025 to $8.91 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.8%. This expansion in past periods can be attributed to factors such as rising UV exposure and sunburn incidence, the limited availability of effective topical agents, an increasing prevalence of skin cancer, the growth of dermatology infrastructure, and the adoption of conventional surgical procedures.

The actinic keratosis market is projected to experience robust expansion over the coming years, with its valuation expected to reach $11.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This anticipated growth can be attributed to several factors, including the development of advanced photodynamic therapies, an increasing application of combined topical and procedural treatments, the expansion of hospital and dermatology clinic networks, heightened consumer awareness regarding early intervention, and the introduction of innovative homecare treatment solutions. Key trends influencing the market during the forecast period involve a growing emphasis on sun protection and skin health awareness, the rising adoption of non-invasive photodynamic therapy, an increase in the usage of topical therapeutics for early-stage actinic keratosis, the proliferation of dermatology clinics and homecare treatment options, and a growing preference for combination therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

What Factors Are Contributing To The Growth Of The Actinic Keratosis Market?

The actinic keratosis market is anticipated to expand due to the rising incidence of severe sunburns. These intense skin burns, known as severe sunburns, stem from overexposure to ultraviolet (UV) radiation, leading to symptoms such as redness, pain, swelling, and occasionally blisters. Contributing factors to sunburns include extended exposure to ultraviolet (UV) radiation, insufficient sun protection, more outdoor pursuits during intense UV periods, and increasing temperatures resulting from climate change. Sunburns induce actinic keratosis by inflicting DNA damage in skin cells via ultraviolet (UV) radiation, which creates mutations that impede normal cellular function, subsequently forming precancerous lesions, particularly after recurrent or prolonged sun exposure. For example, data from May 2024, provided by Melanoma Focus, a UK-based charity, indicates that during 2022-23, 201 hospital admissions were linked to sunburns, comprising 89 children and 25 babies under one year old. Furthermore, the charity discovered that 66% of UK adults aged 16-65 recalled having sunburns in childhood, with 65% of these individuals enduring severe sunburns accompanied by blisters at least once. This percentage climbed to 77% for individuals possessing light, pale, or white skin. Consequently, the growing incidence of severe sunburns is fueling the expansion of the actinic keratosis market.

How Are Segments Identified Within The Actinic Keratosis Market Segment Framework?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies

3) By End-User: Hospitals, Dermatology Clinics, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Combination Therapies

What Trends Are Shaping The Future Of The Actinic Keratosis Market?

Leading firms within the actinic keratosis market are concentrating their efforts on creating topical ointments aimed at effectively addressing and removing precancerous lesions, lowering recurrence rates, and boosting patient adherence through shorter treatment times and better safety profiles. These topical ointments consist of medicated creams or gels directly applied to the affected skin, containing active ingredients like tirbanibulin, which function by targeting abnormal keratinocytes to manage precancerous lesions. An example of this is in June 2024, when Almirall SA, a biopharmaceutical company based in Spain, obtained approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) allowing the expanded application area for its medication, Klisyri, up to 100 cm2. Klisyri (tirbanibulin) 1% ointment acts as a microtubule inhibitor, formulated to hinder the uncontrolled growth of abnormal keratinocytes, thereby effectively diminishing both the count and dimensions of precancerous lesions in the treatment of actinic keratosis (AK) located on the face or scalp.

Who Are The Companies Competing Within The Actinic Keratosis Market?

Major companies operating in the actinic keratosis market are Galderma SA, LEO Pharma A/S, Almirall S.A., Bausch Health Companies Inc., Perrigo Company plc, Pfizer Inc, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GSK plc, Amgen Inc., Incyte Corporation, Aclaris Therapeutics Inc., Biofrontera AG, Hill Dermaceuticals Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Viatris Inc.

Get The Full Actinic Keratosis Market Report:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Region Is The Top Contributor To The Actinic Keratosis Market By Share?

North America was the largest region in the actinic keratosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Actinic Keratosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Browse Through More Reports Similar to the Global Actinic Keratosis Market 2026, By The Business Research Company

Keloids Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

Neurotrophic Keratitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Scleroderma Market Report 2026

https://www.thebusinessresearchcompany.com/report/scleroderma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795